Home › Forums › General Discussion › Repeat challenge for in-use stability testing of sterile drug products in EMA › Reply To: Repeat challenge for in-use stability testing of sterile drug products in EMA
Hi,
Looks like the requirement is about continuing preservative effectiveness testing throughout the extended period (56 days) with perhaps weekly test intervals (will require sufficient in-use exposure sample quantity). Curious to see what others think. If this reply is read in time, there is an In-Use Discussion webinar hosted by AAPS at 3 pm eastern on Thursday, May 9. That would be a great forum in which to raise this question. https://www.linkedin.com/feed/update/urn:li:activity:7187205237856743425/
John O’Neill
StabilityHub Editor